Sign In
Buy LLY
$1,116.11
-5.06 (-0.451%)
At Close: Aug 04, 2026
Lilly, J&J and AbbVie Hit New Highs
12:49pm, Friday, 26'th Jun 2026
Healthcare stocks outperformed the broader market on Friday, with Eli Lilly (LLY), Johnson and Johnson (JNJ) and AbbVie (ABBV) among the major names hitting fresh
Eli Lilly shares rise after EU panel backs expanded use of Jaypirca
11:00am, Friday, 26'th Jun 2026
Eli Lilly and Co (NYSE:LLY) shares climbed nearly 6% on Friday after the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommended approval of Jaypirca (pirtobrutin
Eli Lilly (LLY) is a Top-Ranked Momentum Stock: Should You Buy?
10:57am, Friday, 26'th Jun 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) acro
The positive opinion is based on results from the Phase 3 BRUIN CLL-313 and BRUIN CLL-314 trials, previously presented at the 2025 American Society of Hematology Annual Meeting and published in The Jo
Eli Lilly shares rise after EU panel backs expanded use of Jaypirca
06:56am, Friday, 26'th Jun 2026
Eli Lilly and Co (NYSE:LLY) shares climbed nearly 6% on Friday after the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP)...
What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management
06:45am, Thursday, 25'th Jun 2026
A new Medicare pathway, the Medicare GLP-1 Bridge program, makes Lilly's obesity medicines – a daily pill or the number 1 most prescribed injectable – accessible to eligible Medicare Part D patien
Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
08:45am, Wednesday, 24'th Jun 2026
INDIANAPOLIS, June 24, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Centessa Pharmaceuticals plc. Centessa is a clinical-stage
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly
09:38pm, Tuesday, 23'rd Jun 2026
Abbisko Cayman said on Wednesday that its Shanghai-based unit Abbisko Therapeutics has entered into a strategic research collaboration and license agreement with Eli Lilly.
Trump visits Mack Trucks plant in battleground Pennsylvania district to tout economic agenda as midterms loom
09:36pm, Tuesday, 23'rd Jun 2026
Donald Trump visited the Mack Trucks facility in Macungie, Pennsylvania, to promote his economic agenda in a key battleground district ahead of the midterm elections.
Biotech's Silent Resurgence (5-Year Base Breakout)
05:21pm, Tuesday, 23'rd Jun 2026
The biotech sector's fundamentals are shifting rapidly-and the smartest money on Wall Street is already quietly rotating into the sector.
How Eli Lilly Became a $1 Trillion Company
01:34pm, Tuesday, 23'rd Jun 2026
Mounjaro and Zepbound turned Eli Lilly into a trillion-dollar pharmaceutical giant. But every blockbuster drug eventually faces competition.
Eli Lilly says Trump pricing policy will affect obesity drug launches in Europe
12:10pm, Tuesday, 23'rd Jun 2026
Eli Lilly expects to launch its weight-loss pill in Europe and Britain in the second half of 2026 or early 2027, with the drugmaker targeting the out-of-pocket telehealth market as it has done i
Fund manager names 3 non-AI stocks to own as Intel, AMD sink amid broader tech rout
11:51am, Tuesday, 23'rd Jun 2026
The tech sector is experiencing a sharp global sell-off today, dragging down chipmakers like Intel, AMD, Micron, and even the artificial intelligence (AI) darling – Nvidia. What's driving this weakn
Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock
10:01am, Tuesday, 23'rd Jun 2026
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
